pharma
Berlin-Chemie AG
Berlin-Chemie AG patent portfolio — 25 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- EU
- Founded
- 1890
- Programs
- 0
- Drugs
- 0
- Patents
- 25
Berlin-Chemie AG patents
25 pharmaceutical patents indexed for Berlin-Chemie AG. 2 expire within 24 months.
Berlin-Chemie AG has 25 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
WO 2024252263
COMPOSITIONS SOLIDES DE DICHLORHYDRATE D'ÉLACESTRANT, LEURS PROCÉDÉS DE FABRICATION ET MÉTHODES DE TRAITEMENT LES UTILISANT
granted -
CA 3259243
POLYTHÉRAPIE ANTICANCÉREUSE COMPRENANT UN INHIBITEUR DE BCL-2
granted -
WO 2024023766
POLYTHÉRAPIE À BASE D'INHIBITEUR DE P13K
granted -
CA 3259252
POLYTHÉRAPIE ANTICANCÉREUSE COMPRENANT UN INHIBITEUR DE FLT3
granted -
WO 2022029639
FORMULATIONS PHARMACEUTIQUES AMÉLIORÉES COMPRENANT DES INHIBITEURS DE PI3K
granted -
US 2021015826
ANTICANCER PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPY
granted -
US 2020040086
PHARMACEUTICAL COMBINATIONS COMPRISING AN ANTI-LY75 ANTIBODY
granted -
CA 3102476
ASSOCIATIONS PHARMACEUTIQUES
granted -
EP 3576795
ORALES SCHILDDRÜSENTHERAPEUTIKUM
granted -
WO 2019197609
ANTICORPS DIRIGÉS CONTRE BST1 POUR PRÉVENIR OU TRAITER LE SYNDROME MYÉLODYSPLASIQUE
granted -
DE 102017122807
Orales Schilddrüsentherapeutikum
granted -
CA 3070264
ASSOCIATIONS PHARMACEUTIQUES COMPRENANT UN ANTICORPS ANTI-BST-1 ET UN ANALOGUE DE CYTIDINE
granted -
EP 3169322
DIÄTETISCHE ZUSAMMENSETZUNG MIT ANTIDYSLIPIDÄMISCHER AKTIVITÄT
granted -
PH 12016500580
CONJUGATED ANTIBODIES AGAINST LY75 FOR THE TREATMENT OF CANCER
granted -
EP 2882753
VERFAHREN ZUR HERSTELLUNG VON PEMETREXED UND EINEM LYSINSALZ DAVON
granted -
PH 12013502690
ANTIBODIES TO ADP-RIBOSYL CYCLASE 2
granted -
WO 2007104583
COMPRIMÉ SÉCABLE AVEC PRÉCISION
granted -
DE 102005046769
Lichtstabile, brivudinhaltige pharmazeutische Formulierung zur Behandlung von Augenherpes (Herpes Ophthalmicus)
granted -
EP 1613300
PHOTOSTABILISIERTE TOPISCHE FORMULIERUNGEN VON KETOPROFEN MIT ZWEI UV-FILTERN
expired -
EP 1488787
Topisch anzuwendende stabilisierte Arzneimittel enthaltend Ketoprofen
expired -
CA 2470629
PREPARATIONS TOPIQUES STABILISEES DE BRIVUDINE
expired -
EP 1297826
Pharmazeutische Zusammensetzung zur nasalen Verabreichung enthaltend einen NK-2 Antagonisten
expired -
WO 03007994
SCHILDDRÜSENTHERAPEUTIKA
expired -
CA 2439319
PROCEDE DE PREPARATION DE (E)-5-(2-BROMOVINYL)-2'-DESOXYURIDINE
expired -
CA 2434743
PREPARATIONS TOPIQUES DE BRIVUDINE STABILISEES
expired
Frequently asked questions
How many patents does Berlin-Chemie AG have?
25 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Berlin-Chemie AG patents expire?
2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.